Development ofNovel CXC Chemokine Receptor 7 (CXCR7)Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic PentapeptideScaffold.

MLA

Shinya Oishi, et al. “Development OfNovel CXC Chemokine Receptor 7 (CXCR7)Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic PentapeptideScaffold.” Journal of Medicinal Chemistry, vol. 58, no. 13, July 2015, pp. 5218–25. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.5b00216.

APA

Shinya Oishi, Tomoko Kuroyanagi, Tatsuhiko Kubo, Nicolas Montpas, Yasushi Yoshikawa, Ryosuke Misu, Yuka Kobayashi, Hiroaki Ohno, Nikolaus Heveker, Toshio Furuya, & Nobutaka Fujii. (2015). Development ofNovel CXC Chemokine Receptor 7 (CXCR7)Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic PentapeptideScaffold. Journal of Medicinal Chemistry, 58(13), 5218–5225. https://doi.org/10.1021/acs.jmedchem.5b00216

Chicago

Shinya Oishi, Tomoko Kuroyanagi, Tatsuhiko Kubo, Nicolas Montpas, Yasushi Yoshikawa, Ryosuke Misu, Yuka Kobayashi, et al. 2015. “Development OfNovel CXC Chemokine Receptor 7 (CXCR7)Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic PentapeptideScaffold.” Journal of Medicinal Chemistry 58 (13): 5218–25. doi:10.1021/acs.jmedchem.5b00216.